Amgen Inc - Total Other Finance Cost
Amgen Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.The Serie's long term average value is -1.01 Billion United States Dollars. It's latest available value, on 09/30/2025, is 0.999 Billion United States Dollars higher, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 12/31/2018, to it's latest available value, on 09/30/2025, is +1.38 Billion.
The Serie's change in United States Dollars from it's maximum value, on 06/30/2025, to it's latest available value, on 09/30/2025, is 0.0 Billion.
Total Other Finance Cost for Related Companies:
| Logo | Name | Market Cap (USD) |
|---|---|---|
 | Eli Lilly and Company - Total Other Finance Cost | 905,699,262,464.00 |
 | Johnson & Johnson - Total Other Finance Cost | 486,508,953,600.00 |
 | AbbVie Inc - Total Other Finance Cost | 399,570,305,024.00 |
 | Roche Holding AG - Total Other Finance Cost | 317,433,206,677.55 |
 | AstraZeneca PLC - Total Other Finance Cost | 280,205,508,085.11 |